Catalyst Wire Dossier Catalyst Wire Dossier

TPX-100

· OrthoTrophix, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TPX-100, covering 2017-04-21 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee [Phase 2]

See pricing